AKT1 and neoplasm: For example, dying or necrotic tumor cells release high-[K+]e, which induces the inhibition of TCR-mediated Akt and mTOR phosphorylation and upregulates inhibitory protein PD-1 which, resulting in profound effects on tumor-resident T cell metabolic pathway and induces T cell suppression (92).